Journal of community genetics · 2026
Rare disease genomics and justice: overview of a workshop at the Fondation Brocher, 22-24 January 2025.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Clarke Angus, Horn Ruth, Avram Elena, Banka Siddarth, Boardman Felicity, Charlton Victoria, Drummond Mike, Favresse Roseline, Ferdinand Angeline, Freis David, Galasso Ilaria, Großmann Nadine Z, Halley Meghan, Henriques Sasha, Honné Hadewych, Houge Sofia Douzgou, Kirmani Salman, Klaiman Tamar Nov, Lalova-Spinks Teodora, Malmgren Charlotta Ingvoldstad, Meade Nick, Nicod Elena, Ormond Kelly E, Prainsack Barbara, Van Esch Hilde, Wonkam Ambroise, Wynn Sarah L, Forzano Francesca
Аннотация
Genomics is transforming health care but its implementation raises challenges. This paper reports a 2025 workshop on justice in the implementation of genomics for rare disorders. The workshop goals were to develop a consensus understanding of the problems faced by rare disease patients and families where justice is at stake, to achieve a shared perspective on support for rare disease patients, and to consider the implications for justice in several areas of rare disease genomics, in both research and healthcare. We heard about the diverse experiences and needs of patients. Inequity between different rare diseases is marked. The need for coordination of care for rare disease patients is under-recognized but good models of rare disease care exist. The value of conscientious professionalism to nurture a rare disease mindset needs to be emphasized in the training of each new generation of healthcare students//trainees. The circumstances of different population groups differ systematically. The needs of indigenous and other historically marginalised groups must also be addressed. However, the subordination of individuals to the benefit of the population (i.e. eugenics) must be resisted. Those engaged in genomics projects or diagnostics may need protection from hype and misuse of their personal data, There are different perspectives on the fair allocation of resources to healthcare and research for rare conditions. Health economics and health technology assessment can be practised equitably, so as to meet the challenges of rare disease clinical trials and address the needs of patients and communities.